These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6945911

  • 1. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
    Anderson J, Krivit W, Chilcote R, Pyesmany A, Chard R, Hammond D.
    Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Vindesine plus L-asparaginase and prednisolone therapy (VDS-VLP therapy) for remission induction in children with relapsed acute lymphoblastic leukemia].
    Hara T, Koike K, Tsukada M, Komiyama A, Akabane T.
    Rinsho Ketsueki; 1983 May; 24(5):540-6. PubMed ID: 6577209
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
    Cáp J, Koza I, Misíková Z, Foltinová A, Strbáková E.
    Neoplasma; 1983 May; 30(1):81-92. PubMed ID: 6339961
    [Abstract] [Full Text] [Related]

  • 5. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA, Nesbit ME, Donaldson MH, Hittle RE, Weiner J, Karon M, Hammond D.
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG, Reaman GH, Wesley R.
    Cancer Treat Rep; 1981 Feb; 65 Suppl 4():93-6. PubMed ID: 6955015
    [Abstract] [Full Text] [Related]

  • 7. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Garay G, Milone J, Dibar E, Pavlovsky S, Kvicala R, Sackmann Muriel F, Montres Varela D, Eppinger-Helft M.
    Cancer Chemother Pharmacol; 1983 Feb; 10(3):224-6. PubMed ID: 6345018
    [Abstract] [Full Text] [Related]

  • 8. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W, Anderson J, Chilcote R, Pyesmany A, Chard R, Hammond D.
    Am J Pediatr Hematol Oncol; 1980 Feb; 2(3):217-21. PubMed ID: 7001942
    [Abstract] [Full Text] [Related]

  • 9. Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse.
    Pavlovsky S, Muriel FS, Eppinger-Helft M, Bustelo P, Garay G, Giuntoli JM, Kvicala R, Divito J, Picón A.
    Cancer Treat Rep; 1983 May; 67(5):425-7. PubMed ID: 6573958
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
    Amato KR, Sallan SE, Lipton JM.
    Cancer Treat Rep; 1984 Feb; 68(2):411-2. PubMed ID: 6583001
    [Abstract] [Full Text] [Related]

  • 11. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U, Mezger J.
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [Abstract] [Full Text] [Related]

  • 12. [Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)].
    Mathe G, Pouillart P, De Vassal F, Delgado M, Schwarzenberg L, Misset JL, Hayat M, Jasmin C, Belpomme D, Musset M.
    Nouv Presse Med; 1976 Jun 05; 5(23):1491. PubMed ID: 1064849
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
    Hijiya N, Stewart CF, Zhou Y, Campana D, Coustan-Smith E, Rivera GK, Relling MV, Pui CH, Gajjar A.
    Cancer; 2008 May 01; 112(9):1983-91. PubMed ID: 18318429
    [Abstract] [Full Text] [Related]

  • 14. [A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone].
    Yoshikawa H, Sao H, Tahara T, Akao Y, Yoshikawa S.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3):515-20. PubMed ID: 6584088
    [Abstract] [Full Text] [Related]

  • 15. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
    Nesbit ME, Sather H, Robison LL, Donaldson M, Littman P, Ortega JA, Hammond GD.
    Cancer Res; 1982 Feb 01; 42(2):674-80. PubMed ID: 7034927
    [Abstract] [Full Text] [Related]

  • 16. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
    Vicarioto M, Rosolen A, Cappellato MG, Zanesco L, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Feb 01; 113(5):663-9. PubMed ID: 2435632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
    Kung FH, Nythan WL, Cuttner J, Falkson G, Lanzkowsky P, Del Duca V, Nawabi IU, Koch K, Pluess H, Freeman A, Burgert EO, Leone LA, Ruymann F, Patterson RB, Degnan T, Hakami N, Pajak TF, Holland J.
    Cancer; 1978 Feb 01; 41(2):428-34. PubMed ID: 272945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.